Patch pumps have already changed the game for a lot of people with diabetes: no tubing, fewer “where do I clip this?” moments, and a setup that can feel more streamlined for daily life. What’s ahead looks even more interesting - companies are pushing for longer wear, bigger reservoirs, smarter automation, and more flexible ecosystems.
Below is a forward-looking roundup of four patch-pump pipelines to watch: Tandem’s tubeless Mobi concept, Beta Bionics’ Mint, Medtronic’s MiniMed Fit, and Insulet’s Omnipod 6. (Heads up: future features and dates can change based on FDA review, clinical testing, and manufacturing timelines).
1) Tandem’s tubeless Mobi: a patch-pump direction for a familiar ecosystem
Tandem has been very open that it’s working toward patch-pump options, including a pathway that would transform Mobi into a tubeless patch device via a novel extended-wear infusion site. Tandem also says a next-generation Mobi patch pump is in its pipeline, leveraging technology from its Sigi acquisition.
What to watch for
- Extended wear: Public reporting links Tandem’s SteadiSet (extended-wear infusion set) with the broader push toward longer-wear pump sites.
- Timeline: Tandem has not pinned a firm consumer launch date for its tubeless Mobi patch device on its public innovations page, but extended-wear components and development milestones are being discussed in 2026-oriented roadmaps.
Why it matters: If a Mobi-based patch approach arrives, it could offer a new middle lane between traditional tubed pumps and disposable pods, especially for people who want the flexibility of a patch form factor but prefer a Tandem ecosystem.
2) Beta Bionics Mint: a fresh patch pump with a different philosophy
Beta Bionics made waves discussing Mint, its in-development patch pump. Reporting from ADA coverage describes Mint as a 3-day patch pump that holds up to 200 units, with a concept that includes a reusable controller and phone compatibility.
What to watch for
- Wear time & capacity: ~3 days and ~200 units puts it in familiar pod territory
- Timing: Beta Bionics has indicated a 2027 window for launch, echoed by analyst coverage and earnings call commentary.
Why it matters: Competition is good. More patch-pump options means more chances for people to find the setup that fits their preferences, budget, and lifestyle.
3) Medtronic MiniMed Fit: bigger reservoir + longer wear ambitions
Medtronic’s MiniMed Fit is one of the most concrete next wave patch pumps on the horizon in terms of reported specs: coverage has repeatedly pointed to ~300 units and ~7-day wear. This is a notable shift as many current pod users are used to ~3 days.
What to watch for
- FDA timing: Medtronic has said it intends to submit Fit to the FDA by fall 2026.
- Development activity: ClinicalTrials.gov includes a Medtronic study referencing 7-day wear adhesive components for the MiniMed Fit payload, one more public signal that development is actively moving forward.
- Launch window: Multiple reports suggest market availability likely no earlier than 2027, though timelines can shift.
Why it matters: If Fit lands with a true 7-day patch wear experience and a 300-unit reservoir, it could be a major quality-of-life upgrade for people who want fewer change days.
4) Omnipod 6: next-gen evolution of the category leader
Insulet has publicly outlined a roadmap that includes Omnipod 6 and has pointed to 2027 as the target launch window.
What to watch for
- Ecosystem upgrades: Insulet has also talked about enhancing the Omnipod 5 ecosystem in 2026 (pending FDA clearance), including broader connectivity and deeper insights, signaling that Omnipod’s software layer and integrations remain a key focus as Omnipod 6 approaches.
- Wear time & reservoir: Insulet’s core platform messaging still emphasizes “up to three days” of insulin delivery for Omnipod pods. Until Insulet publishes exact Omnipod 6 hardware specs, it’s safest to assume the next-gen system may keep the same form factor.
- What’s new: Reporting around Investor Day suggests meaningful algorithm and system improvements are part of the Omnipod 6 story.
Why it matters: Omnipod has defined the patch pump category for years. Omnipod 6 will likely set the tone for what “baseline expectations” become, especially around automation, connectivity, and user experience.
The bottom line: 2026 is about momentum, 2027 looks like a turning point
If you zoom out, the direction is clear: longer wear, bigger reservoirs, and smarter systems that fit more naturally into daily life. With big names signaling patch pump roadmaps and multiple products converging on a 2027 window, the future of patch pumps is less a distant concept and more a pipeline that’s actively taking shape.
Quick disclaimer
Details for in-development devices can change quickly. Always confirm final specs (wear time, reservoir size, CGM compatibility, phone control, waterproofing) on the manufacturer’s site once products are FDA-cleared and commercially released.
